Evidence map›Paper›PMID 42835443›Full record

ArticleJournal of vascular surgery cases and innovative techniques2026

True brachial artery aneurysm secondary to arterial wall infiltration by Langerhans cell histiocytosis.

Pietro Federico Ricciardi, Aurore Roesti, Chiara Saglietti, Laurence de Leval, Marie Nicod Lalonde, Celine Deslarzes-Dubuis

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pietro Federico RicciardiVascular Surgery Unit, Heart and Vessels Department, Lausanne University Hospital, Lausanne, Switzerland.
Aurore RoestiVascular Surgery Unit, Heart and Vessels Department, Lausanne University Hospital, Lausanne, Switzerland.
Chiara SagliettiInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
Laurence de LevalInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
Marie Nicod LalondeNuclear Medicine and Molecular Imaging, Department of Medical Radiology, Lausanne University Hospital, Lausanne, Switzerland.
Celine Deslarzes-DubuisVascular Surgery Unit, Heart and Vessels Department, Lausanne University Hospital, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Langerhans cell histiocytosis is a rare histologic disorder that can affect and damage any tissues and organ in the body. A 40-year-old man with multisystem Langerhans cell histiocytosis presented with a painful distal arm mass. Imaging demonstrated a 3.6-cm true distal brachial artery aneurysm and progressive hypermetabolic activity of the affected artery on the retrospective review of serial positron emission tomography/computed tomography scans. The patient underwent aneurysm resection and arterial reconstruction using a reversed great saphenous vein bypass. Histopathology confirmed infiltration of the intima and media by Langerhans cells with destruction of the elastic lamina. Subsequent disease-specific therapy achieved a complete metabolic response, and vascular reconstruction remains patent.

Indexed as

Arterial infiltrationHumeral artery aneurysmMultifocal Langerhans cells histiocytosisPositron emission tomography/computed tomographyVascular reconstruction

Identifiers

PMID42835443
PMCPMC13635856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.